Market Overview:
The global electronic drug delivery systems market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, technological advancements in electronic drug delivery systems, and rising demand for minimally invasive therapies. Based on type, the global electronic drug delivery systems market is segmented into electronic wearable infusion pumps, electronic autoinjectors, electronic injection pens, and electronic inhalers. The largest share of this market is held by electric wearable infusion pumps due to their growing use in homecare settings for delivering drugs such as insulin and other therapeutic agents directly into the patient’s bloodstream. By application, diabetes accounted for the largest share of the global Electronic Drug Delivery Systems Market in 2017 owing to rising incidence rates of diabetes across all regions globally.
Product Definition:
An electronic drug delivery system is a medical device used to deliver medication to a patient. The device may be a patch, implant, or other form of wearable technology. Electronic drug delivery systems are important because they allow patients to receive medication without having to go through surgery or use needles.
Electronic Wearable Infusion Pumps:
Electronic wearable infusion pumps are medical devices that deliver drugs through the skin using electronic signals. They are battery-powered and can connect to a patient’s medication management software, which allows doctors or nurses to monitor a patient’s drug delivery. The FDA has approved three different types of electronic wearable infusion pumps: ambulatory infusion pump, continuous glucose monitoring system, and insulin management system.
Electronic Autoinjectors:
Electronic autoinjectors are devices that help in the administration of drugs. They comprise a series of pushbuttons, which can be used to administer different doses of drugs. These devices are widely used for the self-administration of insulin by patients suffering from diabetes and have been studied to provide effective drug delivery solutions in various other applications as well (such as Cosmetics).
The global electronic autoinjectors.
Application Insights:
The diabetes application segment held the largest share of 24.1% in 2017 owing to the increasing prevalence of diabetes and rising demand for effective treatment options. According to a study published in The Journal of Diabetes, electronic drug delivery systems can reduce hypoglycemic events by 40%. This factor is expected to drive their adoption over the forecast period.
Electronic wearable infusion pumps are an effective solution for treating type-2 diabetes as they allow precise dosing and offer several advantages such as convenience, comfort, efficiency and ease of use at a reduced cost when compared with insulin pumps. These devices have been studied thoroughly regarding safety and efficacy in patients with type-2 diabetes mellitus; however, there remain some limitations due to lack of large scale clinical trials data regarding this population group.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of chronic diseases, such as diabetes and cardiac disorders, high adoption of technologically advanced devices, and rising awareness about their benefits. Moreover, presence of major key players in this region is also one of the significant factors contributing towards regional growth.
Asia Pacific is anticipated to be the fastest-growing segment over the forecast period owing to various initiatives taken by governments for tackling diabetes and other chronic diseases prevalent in their countries. For instance, China’s National Health Commission (NHC) has planned a number of measures for improving healthcare facilities across China including construction or upgrading 1 million hospitals by 2020 with an investment worth USD X billion over a decade from 2016. Such government initiatives are expected to boost demand for electronic drug delivery systems during the forecast period in Asia Pacific as well as other regions mentioned above.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits of people. According to a study by the World Health Organization (WHO), it is estimated that around 60% of all deaths are caused by chronic diseases such as heart disease, stroke, cancer, and diabetes. This is expected to drive the demand for electronic drug delivery systems in the coming years.
- Technological advancements: The electronic drug delivery systems market is witnessing rapid technological advancements due to which new and innovative products are being launched in the market on a regular basis. This has helped boost the growth of this market considerably over the past few years.
- Rising geriatric population: The global geriatric population is growing at a rapid pace due to various factors such as improved healthcare facilities and rising life expectancy rates across different regions worldwide. As this population segment tends to be more susceptible to various health conditions, they require constant medication which can be delivered through electronic drug delivery systems effectively and efficiently without any hassles whatsoever thereby driving its demand in future years as well..
Scope Of The Report
Report Attributes
Report Details
Report Title
Electronic Drug Delivery Systems Market Research Report
By Type
Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pens, Electronic Inhalers
By Application
Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD, Other Indications
By Companies
Medtronic, Novo Nordisk, Insulet, Bayer, United Therapeutics, AstraZeneca, Tandem Diabetes Care, Merck, Amgen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Electronic Drug Delivery Systems Market Report Segments:
The global Electronic Drug Delivery Systems market is segmented on the basis of:
Types
Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pens, Electronic Inhalers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD, Other Indications
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Novo Nordisk
- Insulet
- Bayer
- United Therapeutics
- AstraZeneca
- Tandem Diabetes Care
- Merck
- Amgen
Highlights of The Electronic Drug Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electronic Wearable Infusion Pumps
- Electronic Autoinjectors
- Electronic Injection Pens
- Electronic Inhalers
- By Application:
- Diabetes
- Multiple Sclerosis
- Cardiovascular Disease
- Asthma & COPD
- Other Indications
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Electronic Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Electronic drug delivery systems (EDDS) are a type of medical device that helps to improve the speed, accuracy, and efficiency of medication administration. EDDS can be used in hospitals and clinics to dispense medications directly to patients' rooms or beds. They can also be used in pharmacies and other health care settings to deliver medications directly to patients' hands.
Some of the major companies in the electronic drug delivery systems market are Medtronic, Novo Nordisk, Insulet, Bayer, United Therapeutics, AstraZeneca, Tandem Diabetes Care, Merck, Amgen.
The electronic drug delivery systems market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Electronic Drug Delivery Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Electronic Drug Delivery Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Electronic Drug Delivery Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Electronic Drug Delivery Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Electronic Drug Delivery Systems Market Size & Forecast, 2018-2028
4.5.1 Electronic Drug Delivery Systems Market Size and Y-o-Y Growth
4.5.2 Electronic Drug Delivery Systems Market Absolute $ Opportunity
Chapter 5 Global Electronic Drug Delivery Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Electronic Drug Delivery Systems Market Size Forecast by Type
5.2.1 Electronic Wearable Infusion Pumps
5.2.2 Electronic Autoinjectors
5.2.3 Electronic Injection Pens
5.2.4 Electronic Inhalers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Electronic Drug Delivery Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Electronic Drug Delivery Systems Market Size Forecast by Applications
6.2.1 Diabetes
6.2.2 Multiple Sclerosis
6.2.3 Cardiovascular Disease
6.2.4 Asthma & COPD
6.2.5 Other Indications
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Electronic Drug Delivery Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Electronic Drug Delivery Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Electronic Drug Delivery Systems Analysis and Forecast
9.1 Introduction
9.2 North America Electronic Drug Delivery Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Electronic Drug Delivery Systems Market Size Forecast by Type
9.6.1 Electronic Wearable Infusion Pumps
9.6.2 Electronic Autoinjectors
9.6.3 Electronic Injection Pens
9.6.4 Electronic Inhalers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Electronic Drug Delivery Systems Market Size Forecast by Applications
9.10.1 Diabetes
9.10.2 Multiple Sclerosis
9.10.3 Cardiovascular Disease
9.10.4 Asthma & COPD
9.10.5 Other Indications
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Electronic Drug Delivery Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Electronic Drug Delivery Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Electronic Drug Delivery Systems Market Size Forecast by Type
10.6.1 Electronic Wearable Infusion Pumps
10.6.2 Electronic Autoinjectors
10.6.3 Electronic Injection Pens
10.6.4 Electronic Inhalers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Electronic Drug Delivery Systems Market Size Forecast by Applications
10.10.1 Diabetes
10.10.2 Multiple Sclerosis
10.10.3 Cardiovascular Disease
10.10.4 Asthma & COPD
10.10.5 Other Indications
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Electronic Drug Delivery Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Electronic Drug Delivery Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Electronic Drug Delivery Systems Market Size Forecast by Type
11.6.1 Electronic Wearable Infusion Pumps
11.6.2 Electronic Autoinjectors
11.6.3 Electronic Injection Pens
11.6.4 Electronic Inhalers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Electronic Drug Delivery Systems Market Size Forecast by Applications
11.10.1 Diabetes
11.10.2 Multiple Sclerosis
11.10.3 Cardiovascular Disease
11.10.4 Asthma & COPD
11.10.5 Other Indications
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Electronic Drug Delivery Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Electronic Drug Delivery Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Electronic Drug Delivery Systems Market Size Forecast by Type
12.6.1 Electronic Wearable Infusion Pumps
12.6.2 Electronic Autoinjectors
12.6.3 Electronic Injection Pens
12.6.4 Electronic Inhalers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Electronic Drug Delivery Systems Market Size Forecast by Applications
12.10.1 Diabetes
12.10.2 Multiple Sclerosis
12.10.3 Cardiovascular Disease
12.10.4 Asthma & COPD
12.10.5 Other Indications
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Electronic Drug Delivery Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Electronic Drug Delivery Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Electronic Drug Delivery Systems Market Size Forecast by Type
13.6.1 Electronic Wearable Infusion Pumps
13.6.2 Electronic Autoinjectors
13.6.3 Electronic Injection Pens
13.6.4 Electronic Inhalers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Electronic Drug Delivery Systems Market Size Forecast by Applications
13.10.1 Diabetes
13.10.2 Multiple Sclerosis
13.10.3 Cardiovascular Disease
13.10.4 Asthma & COPD
13.10.5 Other Indications
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Electronic Drug Delivery Systems Market: Competitive Dashboard
14.2 Global Electronic Drug Delivery Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Novo Nordisk
14.3.3 Insulet
14.3.4 Bayer
14.3.5 United Therapeutics
14.3.6 AstraZeneca
14.3.7 Tandem Diabetes Care
14.3.8 Merck
14.3.9 Amgen
